Background illustration for clinical trials search

Leukemia Clinical Trials

Browse 1,314 Leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption

for
HIV
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05419024

Phase2, Recruiting

The T Cell Activator of Cell Killing ("TACK") IT ON" STUDY

for
Hiv
Location: Toronto
Sponsor: University of Toronto

Sex: All

Age: 18 - 70+

Code: NCT06823596

Recruiting

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

for
AML, ALL, MDS, MPD Withou Myelofibrosis, NHL or HL,
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 0 - 21

Code: NCT04644016

Phase2, Recruiting

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

for
Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma,
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06736613

Phase2, Recruiting

A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)

for
Breast Cancer, HER2-positive
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT05035836

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study Evaluating An Integrated Pharmacy Digital Diary and Delivery Strategy to Increase PrEP Use Among MSM and TGW

for
HIV Prevention, Pre-exposure Prophylaxis (PrEP), Risk Reduction,
Location: San Francisco CA
Sponsor: Public Health Foundation Enterprises, Inc.

Sex: Male

Age: 18+

Code: NCT05474313

Recruiting

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

for
Non-small Cell Lung Cancer,
Location: Boston MA, New York NY, New Brunswick NJ, Pittsburgh PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05877599

Phase1, Recruiting

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

for
Myelodysplastic Syndromes, Cytopenia
Location: Shirley NY, Hackensack NJ, Bethesda MD, Miami FL,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT04419649

Phase2, Recruiting

The Use of Leukapheresis to Support HIV Pathogenesis Studies

for
HIV
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT01161199

Recruiting

Kadcyla And Neratinib for Interception of HER2+ Breast Cancer With Molecular Residual Disease

for
Breast Cancer, HER2-positive Breast Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT05388149

Phase2, Recruiting

Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Richmond VA, Columbus OH, Minneapolis MN
Sponsor: Yazeed Sawalha

Sex: All

Age: 18+

Code: NCT06536049

Phase1, Phase2, Recruiting

Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

for
GATA2, Immunodeficiency, MDS
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 6 - 70

Code: NCT01861106

Phase2, Recruiting

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

for
HIV, Kaposi's Sarcoma, Lymphomas,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT00006518

Recruiting

HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)

for
Hiv, Alcohol Drinking, Fall, Cannabis Use
Location: West Haven CT
Sponsor: Yale University

Sex: All

Age: 50+

Code: NCT06513819

Phase1, Recruiting

Improving HIV Care Continuum Outcomes Among Formerly Incarcerated Individuals Through Critical Time Legal Interventions

for
HIV
Location: Orlando FL
Sponsor: University of Central Florida

Sex: All

Age: 18 - 70+

Code: NCT06171919

Recruiting

HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy

for
PrEP, HIV, Incarceration
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT06919419

Recruiting

Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant

for
Myelodysplastic Syndromes
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18 - 70+

Code: NCT04742634

Phase1, Phase2, Recruiting

Health Effects of the Standardized Research E-Cigarette in Smokers With HIV Smokers With HIV

for
HIV
Location: Providence RI
Sponsor: Brown University

Sex: All

Age: 18+

Code: NCT03862924

Recruiting

Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP

for
Hiv, Opioid Use Disorder
Location: New Haven CT
Sponsor: University of Connecticut

Sex: All

Age: 18+

Code: NCT05669534

Recruiting

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

for
Myelodysplastic Syndrome
Location: Boston MA, Lebanon NH, Stony Brook NY, Long Branch NJ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06577441

Phase2, Recruiting

What are clinical trials for leukemia?

Clinical trials for leukemia are research studies designed to evaluate new treatments, therapies, or diagnostic methods for different types of leukemia, a group of cancers that affect the blood and bone marrow. These trials aim to discover more effective ways to treat leukemia, manage its symptoms, and improve patient outcomes. They may involve testing new drugs, combinations of existing treatments, targeted therapies, immunotherapies, or novel approaches like gene therapy.

Why are leukemia clinical trials important?

Leukemia clinical trials are crucial because they drive advancements in treatment by testing new therapies, improving existing ones, and exploring novel approaches to manage and potentially cure the disease. These trials provide essential data on the safety and effectiveness of new treatments, which can lead to better outcomes and fewer side effects compared to current options.

Types of clinical trials for leukemia

Why participate in a leukemia clinical trial

Who can participate in a clinical trial for leukemia?

How to enroll in a leukemia clinical trial